|
1
|
World Kidney Day, . Chronic Kidney
Disease. 2015.http://www.worldkidneyday.org/faqs/chronic-kidney-disease/Accessed
October 10, 2014.
|
|
2
|
Jha V, Garcia-Garcia G, Iseki K, Li Z,
Naicker S, Plattner B, Saran R, Wang AY and Yang CW: Chronic kidney
disease: Global dimension and perspectives. Lancet. 382:260–272.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Couser WG, Remuzzi G, Mendis S and Tonelli
M: The contribution of chronic kidney disease to the global burden
of major noncommunicable diseases. Kidney Int. 80:1258–1270. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Harambat J, van Stralen KJ, Kim JJ and
Tizard EJ: Epidemiology of chronic kidney disease in children.
Pediatr Nephrol. 27:363–373. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Warady BA and Chadha V: Chronic kidney
disease in children: The global perspective. Pediatr Nephrol.
22:1999–2009. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bowden DW: Genetics of kidney disease.
Kidney Int Suppl. 83:S8–S12. 2003. View Article : Google Scholar
|
|
7
|
Lei HH, Perneger TV, Klag MJ, Whelton PK
and Coresh J: Familial aggregation of renal disease in a
population-based case-control study. J Am Soc Nephrol. 9:1270–1276.
1998.PubMed/NCBI
|
|
8
|
Hsu CY, Lin F, Vittinghoff E and Shlipak
MG: Racial differences in the progression from chronic renal
insufficiency to end-stage renal disease in the United States. J Am
Soc Nephrol. 14:2902–2907. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Freedman BI, Spray BJ, Tuttle AB and
Buckalew VM Jr: The familial risk of end-stage renal disease in
African Americans. Am J Kidney Dis. 21:387–393. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Köttgen A, Pattaro C, Böger CA,
Fuchsberger C, Olden M, Glazer NL, Parsa A, Gao X, Yang Q, Smith
AV, et al: New loci associated with kidney function and chronic
kidney disease. Nat Genet. 42:376–384. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liakopoulos V, Georgianos PI,
Eleftheriadis T and Sarafidis PA: Epigenetic mechanisms and kidney
diseases. Curr Med Chem. 18:1733–1739. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dwivedi RS, Herman JG, McCaffrey TA and
Raj DSC: Beyond genetics: Epigenetic code in chronic kidney
disease. Kidney Int. 79:23–32. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Slack JM: Conrad Hal Waddington: The last
Renaissance biologist? Nat Rev Genet. 3:889–895. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nanney DL: Epigenetic control systems.
Proc Natl Acad Sci USA. 44:712–717. 1958. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Riggs A, Martienssen R and Russo V:
Epigenetic mechanisms of gene regulation. 32. Cold Spring Harbor
Laboratory Press; 1996
|
|
16
|
Bird A: Perceptions of epigenetics.
Nature. 447:396–398. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Berger SL, Kouzarides T, Shiekhattar R and
Shilatifard A: An operational definition of epigenetics. Genes Dev.
23:781–783. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bonasio R, Tu S and Reinberg D: Molecular
signals of epigenetic states. Science. 330:612–616. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Link A, Balaguer F and Goel A: Cancer
chemoprevention by dietary polyphenols: Promising role for
epigenetics. Biochem Pharmacol. 80:1771–1792. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sadikovic B, Al-Romaih K, Squire JA and
Zielenska M: Cause and consequences of genetic and epigenetic
alterations in human cancer. Curr Genomics. 9:394–408. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Luch A: Nature and nurture-lessons from
chemical carcinogenesis. Nat Rev Cancer. 5:113–125. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Perna AF, Ingrosso D, Galletti P, Zappia V
and De Santo NG: Membrane protein damage and methylation reactions
in chronic renal failure. Kidney Int. 50:358–366. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Robertson KD and Wolffe AP: DNA
methylation in health and disease. Nat Rev Genet. 1:11–19. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ingrosso D, Cimmino A, Perna AF, Masella
L, De Santo NG, De Bonis ML, Vacca M, D'Esposito M, D'Urso M,
Galletti P, et al: Folate treatment and unbalanced methylation and
changes of allelic expression induced by hyperhomocysteinaemia in
patients with uraemia. Lancet. 361:1693–1699. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ptak C and Petronis A: Epigenetics and
complex disease: From etiology to new therapeutics. Annu Rev
Pharmacol Toxicol. 48:257–276. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Huang Y, Chang X, Lee J, Cho YG, Zhong X,
Park IS, Liu JW, Califano JA, Ratovitski EA, Sidransky D, et al:
Cigarette smoke induces promoter methylation of single-stranded
DNA-binding protein 2 in human esophageal squamous cell carcinoma.
Int J Cancer. 128:2261–2273. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nakajima K, Takeoka M, Mori M, Hashimoto
S, Sakurai A, Nose H, Higuchi K, Itano N, Shiohara M, Oh T, et al:
Exercise effects on methylation of ASC gene. Int J Sports Med.
31:671–675. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Oommen AM, Griffin JB, Sarath G and
Zempleni J: Roles for nutrients in epigenetic events. J Nutr
Biochem. 16:74–77. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Duthie SJ: Folic acid deficiency and
cancer: Mechanisms of DNA instability. Br Med Bull. 55:578–592.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Peterson CL and Laniel MA: Histones and
histone modifications. Curr Biol. 14:R546–R551. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jenuwein T: Re-SET-ting heterochromatin by
histone methyltransferases. Trends Cell Biol. 11:266–273. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tang W, Luo XY and Sanmuels V: Gene
silencing: Double-stranded RNA mediated mRNA degradation and gene
inactivation. Cell Res. 11:181–186. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wassenegger M: The role of the RNAi
machinery in heterochromatin formation. Cell. 122:13–16. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Schena FP, Serino G and Sallustio F:
MicroRNAs in kidney diseases: New promising biomarkers for
diagnosis and monitoring. Nephrol Dial Transplant. 29:755–763.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Woroniecki R, Gaikwad AB and Susztak K:
Fetal environment, epigenetics, and pediatric renal disease.
Pediatr Nephrol. 26:705–711. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zandi-Nejad K, Luyckx VA and Brenner BM:
Adult hypertension and kidney disease: The role of fetal
programming. Hypertension. 47:502–508. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Luyckx VA and Brenner BM: Low birth
weight, nephron number, and kidney disease. Kidney Int Suppl.
68:S68–S77. 2005. View Article : Google Scholar
|
|
38
|
Alexander BT: Intrauterine growth
restriction and reduced glomerular number: Role of apoptosis. Am J
Physiol Regul Integr Comp Physiol. 285:R933–R934. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hughson MD, Douglas-Denton R, Bertram JF
and Hoy WE: Hypertension, glomerular number, and birth weight in
African Americans and white subjects in the southeastern United
States. Kidney Int. 69:671–678. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hodgin JB, Rasoulpour M, Markowitz GS and
D'Agati VD: Very low birth weight is a risk factor for secondary
focal segmental glomerulosclerosis. Clin J Am Soc Nephrol. 4:71–76.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Bechtel W, McGoohan S, Zeisberg EM, Müller
GA, Kalbacher H, Salant DJ, Müller CA, Kalluri R and Zeisberg M:
Methylation determines fibroblast activation and fibrogenesis in
the kidney. Nat Med. 16:544–550. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
42
|
Sayyed SG, Gaikwad AB, Lichtnekert J,
Kulkarni O, Eulberg D, Klussmann S, Tikoo K and Anders HJ:
Progressive glomerulosclerosis in type 2 diabetes is associated
with renal histone H3K9 and H3K23 acetylation, H3K4 dimethylation
and β phosphorylation at serine 10. Nephrol Dial Transplant.
25:1811–1817. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Gaikwad AB, Sayyed SG, Lichtnekert J,
Tikoo K and Anders HJ: Renal failure increases cardiac histone h3
acetylation, dimethylation, and phosphorylation and the induction
of cardiomyopathy-related genes in type 2 diabetes. Am J Pathol.
176:1079–1083. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Pentz ES, Lopez ML, Kim HS, Carretero O,
Smithies O and Gomez RA: Ren1d and Ren2 cooperate to preserve
homeostasis: Evidence from mice expressing GFP in place of Ren1d.
Physiol Genomics. 6:45–55. 2001.PubMed/NCBI
|
|
45
|
Gomez RA, Pentz ES, Jin X, Cordaillat M
and Lopez ML Sequeira: CBP and p300 are essential for renin cell
identity and morphological integrity of the kidney. Am J Physiol
Heart Circ Physiol. 296:H1255–H1262. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Shi S, Yu L, Chiu C, Sun Y, Chen J,
Khitrov G, Merkenschlager M, Holzman LB, Zhang W, Mundel P, et al:
Podocyte-selective deletion of dicer induces proteinuria and
glomerulosclerosis. J Am Soc Nephrol. 19:2159–2169. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Ho JJ and Marsden PA: Dicer cuts the
kidney. J Am Soc Nephrol. 19:2043–2046. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Harvey SJ, Jarad G, Cunningham J, Goldberg
S, Schermer B, Harfe BD, McManus MT, Benzing T and Miner JH:
Podocyte-specific deletion of dicer alters cytoskeletal dynamics
and causes glomerular disease. J Am Soc Nephrol. 19:2150–2158.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Ho J, Ng KH, Rosen S, Dostal A, Gregory RI
and Kreidberg JA: Podocyte-specific loss of functional microRNAs
leads to rapid glomerular and tubular injury. J Am Soc Nephrol.
19:2069–2075. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Ingrosso D, Cimmino A, Perna AF, Masella
L, De Santo NG, De Bonis ML, Vacca M, D'Esposito M, D'Urso M,
Galletti P, et al: Folate treatment and unbalanced methylation and
changes of allelic expression induced by hyperhomocysteinaemia in
patients with uraemia. Lancet. 361:1693–1699. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Newman PE: Can reduced folic acid and
vitamin B12 levels cause deficient DNA methylation producing
mutations which initiate atherosclerosis? Med Hypotheses.
53:421–424. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Ptak C and Petronis A: Epigenetics and
complex disease: From etiology to new therapeutics. Annu Rev
Pharmacol Toxicol. 48:257–276. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Griffiths EA and Gore SD: DNA
methyltransferase and histone deacetylase inhibitors in the
treatment of myelodysplastic syndromes. Semin Hematol. 45:23–30.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Fukuda N: Development of gene therapies
for cardiovascular and renal diseases by nucleic acid medicines.
Med Chem. 2:13–19. 2006. View Article : Google Scholar : PubMed/NCBI
|
